MRI (Magnetic resonance imaging) is a process regularly used in hospitals for the diagnosing and monitoring process. Use of specific agents makes it more beneficial which are called GBCAs. In this gadolinium is used and which protects the early release of ions.
The ions need to be protected because they can be very harmful to the organs of the body if they are released. These agents are used in 40% of the MRI scans which means that a lot of gadolinium is used for this sole purpose.
The use of GBCAs frequently in all the MRI scans can be the cause of a disease and it can be harmful to the patients according to a recent study on the agents. The gadolinium deposits in the organs of the body which causes NSF (nephrogenic systemic fibrosis)
The study and its results exposed the risk of using the agents and the European Medical Agency took action and restricted the use of agents. Only the clinically approved were brought in use.
The FDA (Food and Drug Administration) has issued a warning against the agents to be used without proper care so they need to double-check everything to use the agents so they do not cause any harm.
The graduates from Kansas State University have decided to enhance the performance of the GBCAs by designing nanoscale GBCAs and assure them to be free of harm.
The nanoscale GBCAs will be of great help because they can differentiate between the normal tissues and the tissues of interest. The dose of the agent is also decreased for better performance.
The nanomaterials are of such benefit that they make it easier to depict the onset of disease by sensing the sudden changes in the body and can prove to be life-saving medicines.
The people who did the study believe that the nanoparticles will be able to help and make their job easier by improving their performance. And the process of MRI will be able to carry out without any harm.